Companies / Massachusetts / Transcode Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Transcode Therapeutics? Who to reach and why now

Transcode Therapeutics is a publicly listed pharmaceutical preparations company in Boston, Massachusetts. It raised $8M in Dec 2024 and its filings name 4 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Massachusetts

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerThomas A. FitzgeraldSEC filing, Dec 2024Named officer in the filing; part of the buying group
Chief Technology OfficerErik MantingSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerMagda MarquetSEC filing, Dec 2024Technology and tooling decisions
Chief Technology OfficerPhilippe CalaisSEC filing, Dec 2024Technology and tooling decisions
Chief Executive OfficerFind with a free trialLakewave contact searchSigns off on new vendors; budget owner
Chief Financial OfficerFind with a free trialLakewave contact searchApproves spend after a raise
For sellersWhy Transcode Therapeutics is worth a call this quarterBuy Window: open · major agreement Oct 2026
Oct 2026Oct 2026

Corporate event

Signed a material agreement

Corporate event
Sep 9Sep 2026

New leadership

Officer or director change

New leadership
$8M

Raised

Equity raise reported to the SEC, Dec 2024. Money arrives before the spending plan does.

Capital
Track Transcode Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Transcode Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 1, 2026Signed a material agreementCorporate eventSEC filing
Sep 9, 2026Officer or director changeNew leadershipSEC filing
Dec 2, 2024Raised $8M in equity from 6 investorsCapitalSEC filing

Reach Transcode Therapeutics with emails that land

Lakewave finds the right people at Transcode Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Transcode Therapeutics with a free trial →

About Transcode Therapeutics

HeadquartersBoston, Massachusetts, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$8M (Dec 2024)

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Alnylam Pharmaceuticals · 35Apnimed · 35Immuneering · 21Climb Bio · 18Cue Biopharma · 4Enveric Biosciences · 2See all 6 with a free trial →

Questions people ask

Did Transcode Therapeutics raise funding in 2024?

Yes. Transcode Therapeutics reported a $8M equity raise to the SEC on Dec 2, 2024 with 6 investors.

Who runs Transcode Therapeutics?

The company's SEC filing, Dec 2024 names Thomas A. Fitzgerald (Executive Officer) among its officers.

Where is Transcode Therapeutics headquartered?

Boston, Massachusetts, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.